Understanding Bioelectrome Signaling

“Every cell holds a voltage. Read enough of them together and you start to hear a language the body has been speaking all along.”

— Erik A. Nilsen, PhD, Co-founder & Chief Technology Officer

We are comfortable with the genome and increasingly with the microbiome. I want to introduce another layer: the bioelectrome — the sum of cellular voltage signals across the body's tissues. Each cell maintains an electrical state, and taken together those states form a kind of language, one the body uses to coordinate growth, repair, and function. The bioelectrome is at once a diagnostic resource we can read and a programmable system we might one day write to.

That dual nature is what makes it compelling to a clinician. A signal you can read is a signal that can warn you. A signal you can write is a signal that can heal.

When the language is disrupted

Disrupted bioelectric signaling shows up across a striking range of conditions — arrhythmias in the heart, epilepsy in the brain, impaired wound healing in the skin, and cancer in many tissues. In each, part of the dysfunction is a breakdown in normal electrical communication. Reading the bioelectrome, then, is not an abstraction; it is a way of detecting trouble in the medium where much of it actually unfolds.

An abstract rendering of electrical signals. Making sense of all that data is the hard part. Electrome's Knowledge Graph is designed to integrate biopotential measurements, waveform-response profiles, and clinical outcomes, so that AI can help design therapy grounded in how a given patient's tissue actually behaves. The aim is to turn scattered electrical readings into actionable understanding.

“Map the bioelectrome and you get a blueprint. Everything we build downstream depends on the fidelity of that map.”

— Erik A. Nilsen, PhD, Co-founder & Chief Technology Officer

From map to medicine

The translational possibilities are concrete. A well-read bioelectrome could help guide the timing of wound therapy, identify arrhythmogenic zones in the heart, target oncologic regions, and monitor for early signs of transplant rejection. The roadmap extends toward waveform-based therapies, integration with electronic records and telehealth, and eventual expansion into rare and pediatric diseases where few options exist.

Underpinning all of it is an integrated system — intelligent electrodes, wearable sensors, cloud analytics, and closed-loop optimization. Bioelectric signaling is, in a real sense, a foundational language of biology. Learning to read it well, and someday to write it wisely, is among the most exciting frontiers I can imagine in medicine.

A digital data network.